Horizon Pharma (HZNP) gains on FDA approval

Horizon Pharma plc

shares climbed 3.8% to $28.36 after the company reported that it has received a FDA Fast Track Designation for ACTIMMUNE to treat Friedreich's Ataxia. Share volume was 1.3 million, compared to an all-day average of three million